Outcomes of Refractory Cardiogenic Shock (CS) Patients Supported by Impella 5.5 as a Bridge to Recovery or Advanced HF Therapies.

Autor:	Banayosy, A. M. El1 (AUTHOR), Vanhooser, D.1 (AUTHOR), Bell, M.1 (AUTHOR), Horstmanshof, D.1 (AUTHOR), Cunningham, L.1 (AUTHOR), Corder, M.1 (AUTHOR), Maybauer, M.1 (AUTHOR), Long, J.1 (AUTHOR), El Banayosy, A.1 (AUTHOR)
Zdroj:	Journal of Heart & Lung Transplantation. 2023 Supplement, Vol. 42, pS354-S355. 2p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu